Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma

被引:71
作者
Foss, AJE
Whelehan, I
Hungerford, JL
Anderson, DF
Errington, RD
Kacperek, A
Restori, M
Kongerud, J
Sheen, M
机构
[1] MOORFIELDS EYE HOSP,ONCOL CLIN,LONDON EC1V 2PD,ENGLAND
[2] ST BARTHOLOMEWS HOSP,OCULAR ONCOL SERV,LONDON EC1A 7BE,ENGLAND
[3] DOUGLAS CYCLOTRON UNIT,WIRRAL L63 4JY,MERSEYSIDE,ENGLAND
[4] MOORFIELDS EYE HOSP,DEPT ULTRASOUND,LONDON EC1V 2PD,ENGLAND
关键词
D O I
10.1136/bjo.81.9.748
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims/background-Proton beam radiotherapy can effectively treat primary uveal melanomas of any size. Some patients, however, develop adverse late effects following treatment and the purpose of this study was to determine which factors give rise to a poor local outcome. Methods-The hospital records from a first cohort of 127 patients treated by protons from 1989 to 1992 were reviewed retrospectively. The presence of rubeosis was selected as a measure of significant ocular damage. Split file analysis was performed with 73 cases forming a test group with the remaining 54 cases acting as a validation group. Results-Large tumour size and the presence of retinal detachment were significant, independent risk factors for developing rubeosis for both the test and validation groups. These factors also predicted subsequent enucleation for uncontrolled ocular pain. Patients with tumours too large to plaque and with an associated retinal detachment had a 90% chance of developing rubeosis within 4 years of proton beam radiotherapy. Conclusions-Patients with a uveal melanoma too large for plaque therapy and an associated retinal detachment run a very high risk of developing rubeosis after proton beam radiotherapy and one third of individuals developing rubeosis required enucleation for pain even if local tumour control was satisfactory.
引用
收藏
页码:748 / 754
页数:7
相关论文
共 28 条
[1]  
AUGSBURGER JJ, 1990, OPHTHALMIC SURG LAS, V21, P682
[2]   CLINICAL-PARAMETERS PREDICTIVE OF ENLARGEMENT OF MELANOCYTIC CHOROIDAL LESIONS [J].
AUGSBURGER, JJ ;
SCHROEDER, RP ;
TERRITO, C ;
GAMEL, JW ;
SHIELDS, JA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1989, 73 (11) :911-917
[3]  
BUTLER P, 1994, OPHTHALMOLOGY, V101, P710
[4]   5-YEAR FOLLOW-UP OF HELIUM ION THERAPY FOR UVEAL MELANOMA [J].
CHAR, DH ;
CASTRO, JR ;
KROLL, SM ;
IRVINE, AR ;
QUIVEY, JM ;
STONE, RD .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (02) :209-214
[5]   COMPLICATIONS OF COBALT PLAQUE THERAPY OF CHOROIDAL MELANOMAS [J].
CHAR, DH ;
LONN, LI ;
MARGOLIS, LW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1977, 84 (04) :536-541
[6]  
CHAR DH, 1993, OPHTHALMOLOGY, V100, P1547
[7]   PROGNOSTIC FACTORS FOLLOWING ENUCLEATION OF 111 UVEAL MELANOMAS [J].
COLEMAN, K ;
BAAK, JPA ;
VANDIEST, P ;
MULLANEY, J ;
FARRELL, M ;
FENTON, M .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (11) :688-692
[8]  
CRAWFORD JB, 1987, OPHTHALMOLOGY, V94, P639
[9]   AN APPROACH TO THE MANAGEMENT OF PATIENTS WITH UVEAL MELANOMA [J].
DAMATO, BE .
EYE, 1993, 7 :388-397
[10]   PREDICTIVE FACTORS OF VISUAL OUTCOME AFTER LOCAL RESECTION OF CHOROIDAL MELANOMA [J].
DAMATO, BE ;
PAUL, J ;
FOULDS, WS .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (10) :616-623